Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT01312337 · UNKNOWN
Trial details
- NCT number
- NCT01312337
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-08-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.